Human Organoids Market Size & Share, by Product (Pancreas, Kidney, Lungs, Heart, Liver Models); End-user (Biotech & Pharma, Academic & Research Institutes, Hospitals & Diagnostic Centers) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 3240
  • Published Date: Mar 06, 2023
  • Report Format: PDF, PPT

Companies Dominating the Human Organoids Landscape

top-features-companies
    • BioVT LLC
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Thermo Fisher Scientific Inc.
    • Corning Incorporated
    • Emulate Bio
    • Organovo Holdings Inc.
    • Zen-Bio Inc
    • Hurel Corporation
    • Cellink AB
    • Biopredic International

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • Thermo Fisher Scientific declared to acquire PPD, Inc. for USD 47.50 per share. This acquisition establishes Thermo Fisher as a global leader in the clinical research service industry.

  • CELLINK announced its acquisition of MatTek Corporation to expand its portfolio to advance in-vitro technology.


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 3240
  • Published Date: Mar 06, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The rising incidence of infectious diseases and the growing investment in the advancement of technologies are the major factors driving the market growth.

The market is anticipated to attain a CAGR of 18% over the forecast period, i.e., 2023-2035.

The lack of skilled professionals to conduct diagnostic tests and insufficient funding for research & academia are estimated to be the growth hindering factors for the market expansion.

The market in the Asia Pacific region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Thermo Fisher Scientific Inc., Corning Incorporated, Emulate Bio, Organovo Holdings Inc., Zen-Bio Inc, Hurel Corporation, Cellink AB, Biopredic International, and BioIVT LLC

The company profiles are selected on the basis of revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product, end user, and by region.

The biotech & pharma industry segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying